FibroGen (FGEN) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.06 | 1.17 | 0.21 | -0.28 | 1.94 | 1.94 | |||
| Changes by years, y/y, % | +16% | +11% | -82% | -231% | -796% | -13.3% | |||
FibroGen. Debt/EBITDA
FibroGen. Debt/EBITDA, changes, %
FibroGen (FGEN) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| Debt/EBITDA | -0.20 | -0.24 | -0.39 | 0.76 | 1.94 | 1.94 | ||
| Changes by years, y/y, % | -181% | +829% | +1 281% | +129% | -1 064% | |||
| Changes by quarters, q/q, % | -161% | +21% | +60% | -295% | +155% | |||